Skip to main content
Equibles

Michael C. Donegan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael C. Donegan

Earlier roles on record: CFO at TherapeuticsMD, Inc. (TXMD) until August 17, 2023. TherapeuticsMD, Inc. reported in an 8-K filed August 18, 2023 that Michael C. Donegan resigned as Principal Financial and Accounting Officer, effective August 17, 2023.

“On August 17, 2023, Mr. Michael C. Donegan, the Principal Financial and Accounting Officer of the Company, notified the Company of his decision to resign from such positions, effective as of August 17, 2023.”
TherapeuticsMD, Inc. Form 8-K, filed August 18, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.